REFERENCES
- Papagianni A, Kalovoulos M, Kirmizis D, . Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic hemodialysis patients. Nephrol Dial Transplant. 2003;18:113–119.
- Galli F, Canestrari F, Buoncristiani U. Biological effects of oxidant stress in hemodialysis: The possible roles of vitamin E. Blood Purificat. 1999;17:79–94.
- Kirmizis D, Chatzidimitriou D. Pleiotropic vasoprotective effects of statins: The chicken or the egg? Drug Des Devel Ther. 2009;3:191–204.
- Takemoto M, Liao JK. Pleiotropic effects of 3-Hydroxy-3-Methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001;21:1712–1719.
- Palinski W, Tsimikas S. Immunomodulatory effects of statins: Mechanisms and potential impact on arteriosclerosis. J Am Soc Nephrol. 2002;13:1673–1681.
- Kirmizis D, Papagianni A, Dogrammatzi F, . Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis. J Atheroscler Thromb. 2010;17:1256–1265.
- Kirmizis D, Papagianni A, Belechri AM, Memmos D. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic hemodialysis. Nephrol Dial Transplant. 2011;26:2296–2301.
- Takouli L, Hadjiyannakos D, Metaxaki P, . Vitamin E-coated cellulose acetate dialysis membrane: Long-term effect on inflammation and oxidative stress. Ren Fail. 2010; 32:287–293.
- Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 1998;54:580–589.
- Clermont G, Lecour S, Cabanne JF, . Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 2001;31:233–241.
- Kirmizis D, Chatzidimitriou D. Antiatherogenic effects of vitamin E: The search for the Holy Grail. Vasc Health Risk Manag. 2009;5:767–774.
- Landmesser U, Bahlmann F, Mueller M, . Simvastatin versus ezetimibe: Pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation. 2005;111:2356–2363.
- Oka H, Ikeda S, Koga S, . Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessels. 2008;23:249–256.
- Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin- 1beta-converting enzyme (ICE)–like and cysteine protease protein (CPP)-32–like proteases. J Exp Med. 1997;185:601–607.
- Heermeier K, Schneider R, Heinloth A, Wanner C, Dimmeler S, Galle J. Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein (a). Kidney Int. 1999;56:1310–1312.
- Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781–786.
- No authors listed. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza n’nfarto miocardico. Lancet. 1999;354:447–455.
- Wanner C, Krane V, März W, . Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–248.
- Fellström BC, Jardine AG, Schmieder RE, . Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395–1407.